Market Closed

ENLV
Enlivex Therapeutics Ltd.
$ 1.19
-4.80%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Enlivex Therapeutics Ltd. News

Latest Enlivex Therapeutics Ltd. Stock News & ENLV Headlines

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
13 days ago | globenewswire.com
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
18 days ago | globenewswire.com
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
24 days ago | globenewswire.com
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
a month ago | globenewswire.com
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Shares Shorted: Short Interest Down 59.8% in September
2 months ago | defenseworld.net
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2 months ago | zacks.com
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
4 months ago | globenewswire.com
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
4 months ago | zacks.com
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
4 months ago | zacks.com
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ENLV
Enlivex Therapeutics Ltd.
$ 1.19
-4.80%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago